Astec LifeSciences balance sheet

As of Sep 2026

Total assets: ₹794cr−10.1% on Sep 2025
Shareholders' equity: ₹335cr−19.1% on Sep 2025
Total debt: ₹331cr−10.0% on Sep 2025
Cash and investments: ₹0.1cr−95.2% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	404	424	497	353	287
	0.6	0.2	0.1	148	112
	29.9	30.1	0.0	29.7	30.0
	10.2	5.3	2.2	2.8	1.7
	13.4	19.4	21.2	16.6	14.2
	0.0	0.0	0.0	0.0	0.0
	11.0	20.5	1.4	1.7	3.4
	11.0	20.5	1.4	1.7	3.4
	—	—	0.0	13.7	—
	10.4	—	18.8	10.0	32.1
	479	499	540	576	481
	171	138	160	196	295
	108	248	147	169	155
	0.1	10.0	0.6	0.5	0.5
	1.3	2.2	2.1	2.0	1.7
	2.7	2.6	2.8	0.0	0.0
	0.8	1.1	0.6	2.0	0.6
	113	264	154	173	158
	31.4	41.3	27.8	29.2	46.3
	315	443	341	398	499
	794	942	881	975	979
Equity
	22.3	22.3	19.6	19.6	19.6
	312	368	215	350	400
	335	391	235	369	419
	0.3	0.3	0.3	0.2	0.2
	335	391	235	370	420
Liabilities
	30.0	50.0	280	199	10.9
	—	—	0.3	2.1	1.3
	30.0	50.0	280	201	12.2
	1.5	1.3	0.4	0.4	0.5
	0.0	0.0	0.0	6.8	21.0
	31.5	51.3	281	208	33.7
	301	399	275	295	330
	108	87.7	81.6	89.3	177
	4.0	9.4	6.9	10.3	14.3
	413	496	363	395	522
	1.3	2.4	1.0	1.4	0.7
	13.8	1.4	1.7	1.3	3.6
	428	500	366	397	526
	459	551	646	605	560
	794	942	881	975	979
Trade payables — MSME split
	4.3	7.5	4.1	—	—
	104	80.2	77.5	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTEC₹581.05

Astec LifeSciences Limited

· Chemicals

₹ CrorePeersPUNJABCHEM MOL IPL INSECTICID DHARMAJ BHARATRAS ADVANCE HERANBAMcap ₹1,295 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	286.8	353.5	496.6	423.6	403.5
+ Capital Work-in-Progress	112.4	148.5	0.1	0.2	0.6
+ Investment Property	30.0	29.7	0.0	30.1	29.9
+ Other Intangibles	1.7	2.8	2.2	5.3	10.2
+ Intangibles under Development	14.2	16.6	21.2	19.4	13.4
+ Non-current Investments	0.0	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	3.4	1.7	1.4	20.5	11.0
Non-current Financial Assets	3.4	1.7	1.4	20.5	11.0
+ Deferred Tax Assets	—	13.7	0.0	—	—
+ Other Non-current Assets	32.1	10.0	18.8	—	10.4
Total Non-current Assets	480.6	576.4	540.3	499.0	479.0
Current Assets
+ Inventories	294.8	195.8	159.8	138.0	171.1
+ Trade Receivables	154.9	169.0	147.4	247.7	107.9
+ Cash & Cash Equivalents	0.5	0.5	0.6	10.0	0.1
+ Other Bank Balances	1.7	2.0	2.1	2.2	1.3
+ Short-term Loans	0.0	0.0	2.8	2.6	2.7
+ Other Current Financial Assets	0.6	2.0	0.6	1.1	0.8
Current Financial Assets	157.7	173.4	153.6	263.6	112.9
+ Other Current Assets	46.3	29.2	27.8	41.3	31.4
Total Current Assets	498.9	398.5	341.1	443.0	315.4
Total Assets	979.4	974.9	881.4	942.0	794.4
Equity
+ Equity Share Capital	19.6	19.6	19.6	22.3	22.3
+ Other Equity / Reserves	399.8	349.7	215.1	368.3	312.5
Equity — Owners of Parent	419.4	369.3	234.7	390.6	334.8
+ Minority Interest	0.2	0.2	0.3	0.3	0.3
Total Equity	419.6	369.5	235.0	390.9	335.1
Liabilities
+ Borrowings — Non-current	10.9	199.0	280.0	50.0	30.0
+ Other Non-current Financial Liab	1.3	2.1	0.3	—	—
Non-current Financial Liabilities	12.2	201.1	280.3	50.0	30.0
+ Provisions — Non-current	0.5	0.4	0.4	1.3	1.5
+ Deferred Tax Liabilities	21.0	6.8	0.0	0.0	0.0
Non-current Liabilities	33.7	208.3	280.7	51.3	31.5
+ Borrowings — Current	330.3	294.9	274.5	398.9	300.5
+ Trade Payables	177.2	89.3	81.6	87.7	108.2
+ Other Current Financial Liab	14.3	10.3	6.9	9.4	4.0
Current Financial Liabilities	521.8	394.5	363.0	496.0	412.7
+ Provisions — Current	0.7	1.4	1.0	2.4	1.3
+ Other Current Liabilities	3.6	1.3	1.7	1.4	13.8
Current Liabilities	526.2	397.2	365.7	499.8	427.8
Total Liabilities	559.9	605.4	646.4	551.1	459.3
Total Equity & Liabilities	979.4	974.9	881.4	942.0	794.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	4.1	7.5	4.3
+ Dues to Other Creditors — Current	—	—	77.5	80.2	103.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.